368426-64-6

Basic information

• Product Name: 6-(broMoMethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
• Synonyms: 6-(broMoMethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole;1H-Indazole,6-(bromomethyl)-1-(tetrahydro-2H-pyran-2-yl)-;5-Bromomethyl-1-(tetrahydro-pyran-2-yl)-1H-indazole
• CAS NO: 368426-64-6
• Molecular Formula: C13H15BrN2O
• Molecular Weight: 295.175
• Mol File: 368426-64-6.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 426.9±40.0 °C(Predicted)
• Appearance: /
• Density: 1.54±0.1 g/cm3(Predicted)
• PKA: 0.69±0.30(Predicted)
• CAS DataBase Reference: 6-(broMoMethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(broMoMethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(368426-64-6)
• EPA Substance Registry System: 6-(broMoMethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole(368426-64-6)

Safety Data

• Hazardous Substances Data: 368426-64-6(Hazardous Substances Data)

Relevant articles and documents

Non-covalent thrombin inhibitors

The present invention provides compounds which have a pyrazinone or pyridinone ring at P3 and which feature a six member heterocyclic ring having two ring nitrogen atoms and the remainder of the ring atoms carbon atoms at P1. These compounds have biologic

Thrombin inhibitors having a lactam at P3

The present invention provides compounds having a lactam ring at P3 and at P1 have a six-membered heterocyclic ring having two ring nitrogen ring atoms and the remainder of the ring atoms carbon atoms. These compounds have biological activity as active and potent inhibitors of thrombin. Their pharmaceutically acceptable salts, pharmaceutical compositions thereof and methods of using these compounds and pharmaceutical compositions comprising these compounds as therapeutic agents for treatment of disease states in mammals which are characterized by abnormal thrombosis are also described.